Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways

BACKGROUND: The mTORC1-inhibitor everolimus shows limited efficacy in treating patients with gastro-entero-pancreatic or pulmonary neuroendocrine tumors (NETs), and poor outcome in patients with malignant pheochromocytoma or hepatic carcinoma. We speculated that any effect may be enhanced by antogon...

Descripción completa

Detalles Bibliográficos
Autores principales: Nölting, Svenja, Maurer, Julian, Spöttl, Gerald, Aristizabal Prada, Elke Tatjana, Reuther, Clemens, Young, Karen, Korbonits, Márta, Göke, Burkhard, Grossman, Ashley, Auernhammer, Christoph J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670204/
https://www.ncbi.nlm.nih.gov/pubmed/26636335
http://dx.doi.org/10.1371/journal.pone.0143830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670204/
https://www.ncbi.nlm.nih.gov/pubmed/26636335
http://dx.doi.org/10.1371/journal.pone.0143830

Ejemplares similares